Key points are not available for this paper at this time.
Design
Editorial
This letter raises concerns regarding industry funding, medical writing assistance, and conflicts of interest in review articles about new oral anticoagulants for atrial fibrillation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tom Yates (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: